Global Vinpocetine Market Research Report 2017

July 2017 | 105 pages | ID: GC7DC20DBC2EN
Gen Consulting Company

Abstracts

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon.

The report covers forecast and analysis for the Vinpocetine market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. The study includes drivers and restraints for the Vinpocetine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Vinpocetine market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Vinpocetine market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

The study provides a decisive view on the Vinpocetine market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022.

Key Applications

• Pharmaceutical
• Dietary Supplement

Key Regions

• North America
• Europe
• Asia Pacific
• China

Key Vendors

• Linnea.SA
• Covex/Pioneer Pharma
• Alchem International
• Vital Laboratories
• Gedeon Richter
• Jiangsu Swellxin Bio-Pharm
• Chedom Pharmaceutical
• Northeast Pharm

Key Questions Answered in this Report

• What will the market size be in 2022?
• What are the key factors driving the global Vinpocetine market?
• What are the challenges to market growth?
• Who are the key players in the Vinpocetine market?
• What are the market opportunities and threats faced by the key players?

Contents

PART 1. EXCLUSIVE SUMMARY

PART 2. METHODOLOGY

2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

PART 3. INTRODUCTION

3.1 Definition
3.2 Applications of Vinpocetine
  3.2.1 Pharmaceutical
  3.2.2 Dietary Supplement
3.3 Manufacturing Process

PART 4. MARKET OVERVIEW

4.1 Global Vinpocetine Market, by Volume 2012-2017
  4.1.1 Overview
  4.1.2 Global Vinpocetine Market, by Volume, by Company
  4.1.3 Top 5 Companies by Volume Share
4.2 Global Vinpocetine Market, by Revenue 2012-2017
  4.2.1 Overview
  4.2.2 Global Vinpocetine Market, by Revenue, by Company
  4.2.3 Top 5 Companies by Revenue Share

PART 5. MARKET DYNAMICS

5.1 Market Drivers
5.2 Challenges
5.3 Market Trends

PART 6. SEGMENTATION BY APPLICATION

6.1 Overview
6.2 Pharmaceutical
6.3 Dietary Supplement

PART 7. NORTH AMERICA

7.1 North American Vinpocetine Market Size
7.2 by Country
  7.2.1 United States
  7.2.2 Canada

PART 8. EUROPE

8.1 European Vinpocetine Market Size
8.2 by Country
  8.2.1 Germany
  8.2.2 UK
  8.2.3 France

PART 9. ASIA-PACIFIC

9.1 Asia-Pacific Vinpocetine Market Size
9.2 by Country
  9.2.1 China
  9.2.2 Japan
  9.2.3 India

PART 10. CHINESE VINPOCETINE FINISHED DOSAGE MARKET

10.1 Market Size
10.2 Market by Company
10.3 Prices
10.3 Consumption Balance
10.4 Chinese Key Vendors of Vinpocetine Finised Dosage
  10.4.1 Runhong
  10.4.2 Gedeon Richter
  10.4.3 Zhitong

PART 11. VINPOCETINE MARKET FORECAST

11.1 Global Vinpocetine Market Size 2017-2022
11.2 Global Vinpocetine Market by Region 2017-2022
  11.2.1 North America
  11.2.2 Europe
  11.2.3 Asia-Pacific
11.3 Global Vinpocetine Consumption 2017-2022
11.4 Global Vinpocetine Market by Application 2017-2022

PART 12. COMPANY PROFILES

12.1 Linnea.SA (Switzerland)
  12.1.1 Business Overview
  12.1.2 Products Offered
  12.1.3 Financials
12.2 Covex.S.A. (Spain)
12.3 Alchem International (India)
12.4 Vital Laboratories (India)
12.5 Gedeon Richter (Hungary)
12.6 Jiangsu Swellxin Bio-Pharm (China)
12.7 Chedom Pharmaceutical (China)
12.8 Northeast Pharm (China)

PART 13. APPENDIX

13.1 Abbreviations
13.2 Disclaimer